Teladoc Health (NYSE:TDOC) Earns Hold Rating from Needham & Company LLC

Teladoc Health (NYSE:TDOC)‘s stock had its “hold” rating reaffirmed by equities research analysts at Needham & Company LLC in a research note issued on Thursday,Benzinga reports.

TDOC has been the topic of several other reports. Oppenheimer cut their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Bank of America increased their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. The Goldman Sachs Group boosted their price objective on shares of Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Tuesday, February 18th. Barclays increased their target price on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Eleven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $11.44.

Teladoc Health Stock Down 2.5 %

Shares of NYSE TDOC opened at $10.91 on Thursday. The firm has a market cap of $1.88 billion, a P/E ratio of -1.89 and a beta of 1.04. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $15.95. The firm’s 50 day moving average price is $10.61 and its 200 day moving average price is $9.53.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, sell-side analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current year.

Insiders Place Their Bets

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.95% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

Large investors have recently modified their holdings of the business. Point72 Asset Management L.P. boosted its holdings in Teladoc Health by 57.8% in the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock valued at $76,803,000 after purchasing an additional 3,063,172 shares during the last quarter. Maple Rock Capital Partners Inc. increased its holdings in Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after purchasing an additional 2,331,000 shares during the last quarter. Two Sigma Investments LP acquired a new position in shares of Teladoc Health in the 4th quarter valued at approximately $18,348,000. Two Sigma Advisers LP boosted its stake in shares of Teladoc Health by 213.0% during the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock valued at $20,532,000 after buying an additional 1,537,094 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock worth $167,830,000 after buying an additional 1,029,829 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.